Stanford Medicine Children’s Health, Palo Alto, CA, USAPalo Alto, California, United States
Disclosure information not submitted.
Paper 69 - UPDATED EFFICACY, SAFETY, AND TREATMENT DISCONTINUATION OUTCOMES OF LAROTRECTINIB IN PEDIATRIC PATIENTS WITH TRK FUSION SARCOMAS
Saturday, November 16, 20248:00 AM – 9:00 AM PST